$TTNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TITAN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TITAN PHARMACEUTICALS INC. Get notifications about new insider transactions in TITAN PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Beebe Katherine | President and COO | Option Exercise | A | 4.02 | 150,000 | 603,000 | 150,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Option Exercise | A | 4.02 | 25,000 | 100,500 | 25,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 4.02 | 25,000 | 100,500 | 25,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 4.02 | 25,000 | 100,500 | 25,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 4.02 | 150,000 | 603,000 | 150,000 | |
Jun 07 2019 | TTNP | TITAN PHARMACEUTIC ... | Hallberg Dane | See Remarks | Option Exercise | A | 1.50 | 80,000 | 120,000 | 80,000 | |
Apr 03 2019 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
Apr 03 2019 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
Oct 22 2018 | TTNP | TITAN PHARMACEUTIC ... | Recli Federico Seghi | Director | Buy | P | 0.00 | 200,000 | 0 | 800,845 | 600.8 K to 800.8 K (+33.29 %) |
Sep 26 2018 | TTNP | TITAN PHARMACEUTIC ... | Recli Federico Seghi | Director | Buy | P | 0.00 | 500,000 | 0 | 600,845 | 100.8 K to 600.8 K (+495.81 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 0.25 | 80,000 | 20,000 | 80,000 | |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Buy | P | 0.25 | 80,000 | 20,000 | 102,275 | 22.3 K to 102.3 K (+359.15 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | See Remarks | Option Exercise | A | 0.25 | 300,000 | 75,000 | 300,000 | |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | See Remarks | Buy | P | 0.25 | 300,000 | 75,000 | 435,578 | 135.6 K to 435.6 K (+221.27 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 0.25 | 200,000 | 50,000 | 200,000 | |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Buy | P | 0.25 | 200,000 | 50,000 | 300,000 | 100 K to 300 K (+200.00 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.25 | 400,000 | 100,000 | 400,000 | |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.25 | 400,000 | 100,000 | 556,317 | 156.3 K to 556.3 K (+255.89 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Option Exercise | A | 0.25 | 200,000 | 50,000 | 200,000 | |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Buy | P | 0.25 | 200,000 | 50,000 | 213,000 | 13 K to 213 K (+1,538.46 %) |
Mar 09 2018 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Option Exercise | A | 0.97 | 170,000 | 164,900 | 170,000 | |
Mar 09 2018 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.97 | 170,000 | 164,900 | 170,000 | |
Sep 19 2017 | TTNP | TITAN PHARMACEUTIC ... | Smith Scott Andrew | Director | Option Exercise | A | 1.50 | 10,000 | 15,000 | 10,000 | |
Sep 19 2017 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 1.50 | 10,000 | 15,000 | 10,000 | |
Sep 19 2017 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 1.50 | 10,000 | 15,000 | 10,000 | |
Sep 19 2017 | TTNP | TITAN PHARMACEUTIC ... | Kumar Rajinder | Director | Option Exercise | A | 1.50 | 10,000 | 15,000 | 10,000 | |
Sep 19 2017 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Option Exercise | A | 1.50 | 10,000 | 15,000 | 10,000 | |
Feb 21 2017 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 3.80 | 10,000 | 38,000 | 10,000 | |
Feb 21 2017 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 3.80 | 10,000 | 38,000 | 10,000 | |
Feb 21 2017 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 3.80 | 10,000 | 38,000 | 10,000 | |
Feb 21 2017 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Option Exercise | A | 3.80 | 10,000 | 38,000 | 10,000 | |
Feb 14 2017 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 3.90 | 70,000 | 273,000 | 70,000 | |
Feb 14 2017 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Option Exercise | A | 3.90 | 80,000 | 312,000 | 80,000 | |
Jul 19 2016 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Buy | P | 4.68 | 5,000 | 23,400 | 13,000 | 8 K to 13 K (+62.50 %) |
Jul 19 2016 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Buy | P | 4.95 | 8,000 | 39,600 | 8,000 | 0 to 8 K |
Jul 19 2016 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Buy | P | 4.96 | 10,000 | 49,550 | 135,578 | 125.6 K to 135.6 K (+7.96 %) |
May 31 2016 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Buy | P | 7.03 | 20,000 | 140,600 | 100,000 | 80 K to 100 K (+25.00 %) |
Feb 22 2016 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Buy | P | 3.56 | 11,763 | 41,817 | 125,578 | 113.8 K to 125.6 K (+10.34 %) |
Feb 02 2016 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Option Exercise | A | 5.10 | 89,100 | 454,410 | 89,100 | |
Feb 02 2016 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 5.10 | 79,100 | 403,410 | 79,100 | |
Jan 19 2016 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Buy | P | 2.72 | 5,841 | 15,888 | 113,815 | 108 K to 113.8 K (+5.41 %) |
Jan 14 2016 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Buy | P | 3.16 | 16,363 | 51,707 | 80,000 | 63.6 K to 80 K (+25.71 %) |
Jan 11 2016 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 3.25 | 5,000 | 16,250 | 156,317 | 151.3 K to 156.3 K (+3.30 %) |
Jan 11 2016 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Buy | P | 3.18 | 17,000 | 54,060 | 107,974 | 91 K to 108 K (+18.69 %) |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 5.10 | 10,000 | 51,000 | 10,000 | |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 5.10 | 10,000 | 51,000 | 10,000 | |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 5.10 | 10,000 | 51,000 | 10,000 | |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 5.10 | 10,000 | 51,000 | 10,000 | |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 5.10 | 10,000 | 51,000 | 10,000 | |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Option Exercise | A | 5.10 | 10,000 | 51,000 | 10,000 | |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 5.10 | 170,000 | 867,000 | 170,000 | |
Dec 16 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Option Exercise | A | 5.10 | 180,000 | 918,000 | 180,000 | |
Oct 01 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 3.99 | 200 | 798 | 90,974 | 90.8 K to 91 K (+0.22 %) |
Oct 01 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 3.98 | 500 | 1,990 | 90,774 | 90.3 K to 90.8 K (+0.55 %) |
Sep 29 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 3.62 | 910 | 3,296 | 90,274 | 89.4 K to 90.3 K (+1.02 %) |
Sep 16 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 0.70 | 5,000 | 3,500 | 491,500 | 486.5 K to 491.5 K (+1.03 %) |
Sep 16 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 0.69 | 5,000 | 3,450 | 486,500 | 481.5 K to 486.5 K (+1.04 %) |
Aug 31 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.72 | 50,000 | 35,750 | 832,200 | 782.2 K to 832.2 K (+6.39 %) |
Aug 26 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 0.70 | 50,000 | 34,800 | 481,500 | 431.5 K to 481.5 K (+11.59 %) |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 0.60 | 25,000 | 15,000 | 25,000 | |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 0.60 | 200,000 | 120,000 | 200,000 | |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 0.60 | 12,500 | 7,500 | 12,500 | |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 0.60 | 25,000 | 15,000 | 25,000 | |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 0.60 | 25,000 | 15,000 | 25,000 | |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Option Exercise | A | 0.60 | 240,000 | 144,000 | 240,000 | |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 0.60 | 25,000 | 15,000 | 25,000 | |
Mar 18 2015 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Option Exercise | A | 0.60 | 12,500 | 7,500 | 12,500 | |
Oct 14 2014 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.48 | 100,000 | 48,200 | 707,200 | 607.2 K to 707.2 K (+16.47 %) |
Oct 14 2014 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 0.47 | 92,000 | 43,240 | 356,500 | 264.5 K to 356.5 K (+34.78 %) |
Oct 14 2014 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 0.49 | 24,000 | 11,688 | 0 | -24,000 to 0 (-100.00 %) |
Oct 14 2014 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 0.48 | 100,000 | 47,800 | 0 | -100,000 to 0 (-100.00 %) |
Feb 14 2014 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 0.66 | 25,000 | 16,500 | 25,000 | |
Feb 14 2014 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 0.66 | 25,000 | 16,500 | 25,000 | |
Feb 14 2014 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Grant | A | 0.66 | 100,000 | 66,000 | 215,500 | 115.5 K to 215.5 K (+86.58 %) |
Feb 14 2014 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Grant | A | 0.66 | 100,000 | 66,000 | 682,200 | 582.2 K to 682.2 K (+17.18 %) |
Feb 14 2014 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 0.66 | 25,000 | 16,500 | 25,000 | |
Feb 14 2014 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 0.66 | 25,000 | 16,500 | 25,000 | |
Jun 19 2013 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 0.46 | 50,000 | 22,770 | 115,500 | 65.5 K to 115.5 K (+76.34 %) |
Jun 19 2013 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 0.45 | 50,000 | 22,690 | 463,400 | 413.4 K to 463.4 K (+12.09 %) |
Feb 27 2013 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Option Exercise | M | 1.50 | 50,000 | 75,000 | 0 | |
Feb 27 2013 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | M | 1.50 | 50,000 | 75,000 | 65,500 | 15.5 K to 65.5 K (+322.58 %) |
Feb 27 2013 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | M | 1.50 | 25,000 | 37,500 | 0 | |
Feb 27 2013 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Buy | M | 1.50 | 25,000 | 37,500 | 36,144 | 11.1 K to 36.1 K (+224.34 %) |
Jan 05 2012 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 1.15 | 35,000 | 40,250 | 35,000 | |
Jan 05 2012 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 1.15 | 250,000 | 287,500 | 250,000 | |
Jan 05 2012 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 1.15 | 30,000 | 34,500 | 30,000 | |
Jan 05 2012 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 1.15 | 35,000 | 40,250 | 35,000 | |
Jan 05 2012 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 1.15 | 35,000 | 40,250 | 35,000 | |
Jan 05 2012 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Option Exercise | A | 1.15 | 300,000 | 345,000 | 300,000 | |
Jan 05 2012 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 1.15 | 30,000 | 34,500 | 30,000 | |
Nov 21 2011 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Buy | P | 1.27 | 38,400 | 48,918 | 413,400 | 375 K to 413.4 K (+10.24 %) |
Nov 21 2011 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Buy | P | 1.32 | 25,000 | 32,900 | 65,500 | 40.5 K to 65.5 K (+61.73 %) |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President | Option Exercise | A | 1.40 | 200,000 | 280,000 | 200,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 1.40 | 150,000 | 210,000 | 150,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 1.40 | 35,000 | 49,000 | 35,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 1.40 | 25,000 | 35,000 | 25,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 1.40 | 30,000 | 42,000 | 30,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 20,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 1.40 | 35,000 | 49,000 | 35,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 1.40 | 25,000 | 35,000 | 25,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 1.40 | 35,000 | 49,000 | 35,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 1.40 | 25,000 | 35,000 | 25,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 1.40 | 30,000 | 42,000 | 30,000 | |
Apr 19 2011 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 1.40 | 15,000 | 21,000 | 15,000 | |
Oct 27 2010 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Sell | P | 1.31 | 113,400 | 148,554 | 546,339 | 659.7 K to 546.3 K (-17.19 %) |
Oct 27 2010 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Sell | P | 1.32 | 97,700 | 128,476 | 0 | 97.7 K to 0 (-100.00 %) |
Oct 27 2010 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Sell | P | 1.30 | 14,925 | 19,403 | 0 | 14.9 K to 0 (-100.00 %) |
Oct 27 2010 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Sell | P | 1.30 | 25,987 | 33,783 | 0 | 26 K to 0 (-100.00 %) |
Oct 27 2010 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Sell | P | 1.30 | 39,460 | 51,298 | 0 | 39.5 K to 0 (-100.00 %) |
Oct 27 2010 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Sell | P | 1.30 | 181,188 | 236,269 | 0 | 181.2 K to 0 (-100.00 %) |
Oct 27 2010 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Sell | P | 1.43 | 86,000 | 122,894 | 0 | 86 K to 0 (-100.00 %) |
Dec 12 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 0.04 | 800,000 | 28,000 | 1,000,000 | 200 K to 1000 K (+400.00 %) |
Oct 22 2008 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Grant | A | 0.00 | 200,000 | 0 | 320,580 | 120.6 K to 320.6 K (+165.86 %) |
Oct 22 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Grant | A | 0.00 | 400,000 | 0 | 530,000 | 130 K to 530 K (+307.69 %) |
Oct 22 2008 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Grant | A | 0.00 | 300,000 | 0 | 365,500 | 65.5 K to 365.5 K (+458.02 %) |
Aug 15 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 0.48 | 90,000 | 43,200 | 200,000 | 110 K to 200 K (+81.82 %) |
Aug 15 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 0.36 | 10,000 | 3,600 | 110,000 | 100 K to 110 K (+10.00 %) |
Jul 08 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 0.86 | 24,200 | 20,812 | 100,000 | 75.8 K to 100 K (+31.93 %) |
Jul 08 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 0.88 | 15,000 | 13,200 | 75,800 | 60.8 K to 75.8 K (+24.67 %) |
Jul 08 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 0.70 | 10,800 | 7,560 | 60,800 | 50 K to 60.8 K (+21.60 %) |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Option Exercise | A | 1.52 | 15,000 | 22,800 | 15,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Option Exercise | A | 1.52 | 15,000 | 22,800 | 15,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 1.52 | 25,000 | 38,000 | 25,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 1.52 | 25,000 | 38,000 | 25,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 1.52 | 25,000 | 38,000 | 25,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Option Exercise | A | 1.52 | 10,000 | 15,200 | 10,000 | |
Jun 03 2008 | TTNP | TITAN PHARMACEUTIC ... | BAUER VICTOR J PHD | Director | Option Exercise | A | 1.52 | 15,000 | 22,800 | 15,000 | |
Feb 13 2008 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Buy | P | 1.25 | 20,000 | 25,000 | 95,894 | 75.9 K to 95.9 K (+26.35 %) |
Feb 13 2008 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 1.33 | 30,000 | 39,900 | 50,000 | 20 K to 50 K (+150.00 %) |
Feb 07 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Buy | P | 1.32 | 750 | 989 | 130,000 | 129.3 K to 130 K (+0.58 %) |
Feb 07 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Buy | P | 1.30 | 4,250 | 5,525 | 129,250 | 125 K to 129.3 K (+3.40 %) |
Feb 07 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Buy | P | 1.30 | 5,000 | 6,500 | 125,000 | 120 K to 125 K (+4.17 %) |
Feb 07 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Buy | P | 1.31 | 5,000 | 6,550 | 120,000 | 115 K to 120 K (+4.35 %) |
Feb 07 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Buy | P | 1.33 | 5,000 | 6,650 | 115,000 | 110 K to 115 K (+4.55 %) |
Feb 07 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Buy | P | 1.38 | 10,000 | 13,800 | 110,000 | 100 K to 110 K (+10.00 %) |
Jan 07 2008 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 1.61 | 3,950 | 6,360 | 120,580 | 116.6 K to 120.6 K (+3.39 %) |
Jan 07 2008 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Buy | P | 1.61 | 5,050 | 8,131 | 116,630 | 111.6 K to 116.6 K (+4.53 %) |
Jan 04 2008 | TTNP | TITAN PHARMACEUTIC ... | FARRELL ROBERT EDWARD | Exec Vice President ... | Option Exercise | A | 1.64 | 80,000 | 131,200 | 80,000 | |
Jan 04 2008 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | President & Chief E ... | Option Exercise | A | 1.64 | 25,000 | 41,000 | 25,000 | |
Jan 04 2008 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | Executive VP and CO ... | Option Exercise | A | 1.64 | 125,000 | 205,000 | 125,000 | |
Jan 04 2008 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | Executive Chairman | Option Exercise | A | 1.64 | 150,000 | 246,000 | 150,000 | |
Nov 06 2007 | TTNP | TITAN PHARMACEUTIC ... | Kapp Joachim Friedrich | Director | Buy | P | 1.91 | 20,000 | 38,200 | 20,000 | 0 to 20 K |
Sep 26 2007 | TTNP | TITAN PHARMACEUTIC ... | WEIS KONRAD M PHD | Director | Option Exercise | A | 2.04 | 10,000 | 20,400 | 10,000 | |
Sep 26 2007 | TTNP | TITAN PHARMACEUTIC ... | SMITH LEY S | Director | Option Exercise | A | 2.04 | 15,000 | 30,600 | 15,000 | |
Sep 26 2007 | TTNP | TITAN PHARMACEUTIC ... | Cavalier Eurelio M | Director | Option Exercise | A | 2.04 | 15,000 | 30,600 | 15,000 | |
Sep 26 2007 | TTNP | TITAN PHARMACEUTIC ... | HUCKEL HUBERT E MD | Director | Option Exercise | A | 2.04 | 15,000 | 30,600 | 15,000 | |
Sep 26 2007 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 2.04 | 10,000 | 20,400 | 10,000 | |
Sep 26 2007 | TTNP | TITAN PHARMACEUTIC ... | BUCALO LOUIS R MD | President and CEO | Option Exercise | A | 2.04 | 5,000 | 10,200 | 5,000 |